Firms eye means-plus-function future ahead of Fed Circuit case

Counsel could be more hesitant to recommend means-plus-function claims for life sciences patents if the Federal Circuit rules against Xencor
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: